Table 2 MR imaging findings compared between the nonsurvival and survival groups: Chi-square test
Variables | Total (n = 175) | Nonsurvivors (n = 31) | Survivors (n = 144) | P-value |
|---|---|---|---|---|
Diffuse hyperintense on T2WI | 82(46.9) | 24(77.4) | 58(40.3) | <0.001* |
Patchy enhancement at AP | 85(48.6) | 19(61.3) | 66(45.8) | 0.023* |
Uneven enhancement at PVP | 20(11.4) | 3(9.7) | 17(11.8) | 0.899 |
Gallbladder wall edema | 90(51.4) | 16(51.6) | 74(51.4) | 0.849 |
Periportal edema | 74(42.3) | 10(32.3) | 64(44.4) | 0.441 |
Ascites (mild/moderate/severe) | 87/41/47 | 6/11/14 | 81/30/33 | 0.001* |
Esophageal varix | 84(48.0) | 13(41.9) | 71(49.3) | 0.860 |
Gastric varix | 60(34.3) | 11(35.5) | 49(34.0) | 0.535 |
Umbilical vein patefac | 53(30.3) | 8(25.8) | 45(31.3) | 0.832 |
Portal vein thrombosis | 11(6.3) | 2(6.5) | 9(6.3) | 0.836 |
Splenomegaly | 100(57.1) | 18(58.1) | 82(56.9) | 0.667 |